Screener / SEC EDGAR /CIK 0001830033 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq, OTC Materials · Plastics & Resins

PureCycle Technologies, Inc. PCT

Compare with peers Embed
Earnings releases

Latest results release: Nov 4, 2026

8-K item 2.02, exhibit 99

What PCT's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 4, 2026 · EX-99.1

PureCycle Technologies Reports Third Quarter 2026 Results

Open on SEC

Branded programs shipping, under purchase order, in contract negotiation, or final qualification are expected to reach approximately 45-55 million pounds per year at full ramp, which would approach the 40 to 50% utilization range

P&G products are on shelves; railcar shipments began in October to a large customer for hot lids; and resin is qualified for shampoo closures at a large global cosmetics company with shipments expected in Q4

Ironton produced 5.2 million pounds of PureFive ® resin in Q3, up 14% sequentially; operational issues in Q3 limited production and were resolved; production is now in line with current commercial demand

Thailand construction permit issued; final terms of the project financing under negotiation

ORLANDO, FLA., November 4, 2026—PureCycle Technologies, Inc.(Nasdaq: PCT) (“PureCycle” or the “Company”), a U.S.-based company revolutionizing plastic recycling, today announced results for the third quarter ended September 30, 2026.

Railcar shipments started in October to a large customer for hot lids, representing a program of approximately 7–8 million pounds of expected annual volume once fully ramped

Procter & Gamble (P&G) products are on shelves, including Downy and Tide caps, with first Tide deliveries in October; Gain caps are a new application and another brand color the Company has matched; Vicks ZzzQuil lids are in commercial production

Resin shipments to a large global cosmetics company are expected to begin in Q4 for shampoo closures with 100% recycled content, and a large global personal care company has approved a white grade for deodorant sticks, with the final trial this month

Two major quick-service restaurant cold-cup programs are qualified; launches planned for 2026 moved to 2027 following the New Jersey exemption extension; term sheet conditions are agreed upon, and the supply agreement is under negotiation

New Jersey's extension of its food-contact exemption shifted about 15 food- contact programs, approximately 50 million pounds of expected annual volume once fully ramped, into 2027 and in many cases beyond. The Company has moved its primary sales and marketing effort to non-food applications, where the January 2027 compliance date still applies, with initial positive results in October

Q3 revenue of $2.3 million primarily reflects operational issues in the quarter and the New Jersey delays; strong branded customer and purchase-order momentum in October

Production is now in line with current commercial demand; as programs convert, the priority is supplying each customer consistently to its specification, so production is designed to rise with shipments

On-site compounding transitioned to 24/7 availability and is accelerating many customer programs, with more than 20 grades formulated in-house to meet customers’ specifications

The Company continued to make incremental improvements at Ironton to reduce costs and raise operating efficiency

Long-term feedstock agreement with WM, the largest recycler in North America, for up to 25 million pounds per year of waste polypropylene bales over three years beginning November 2026; the two companies are also continuing to work together on circularity programs with brands

Final terms and conditions of the Thailand project financing are under negotiation

The Company has invested more than $85 million in equipment and engineering for the Rayong, Thailand project to date

Growth projects have reached internal milestones; discretionary spending is on hold until commercial progress at Ironton supports further investment

Total liquidity of $193 million at quarter-end, consisting of cash and cash equivalents, marketable securities and restricted cash, plus the undrawn $200 million revolving credit facility, now extended to September 30, 2028, for total available liquidity of $393 million

Monthly operations spending of $7.8 million in Q3, excluding materials purchases of approximately $2.7 million per month, below the Company's previously guided $8.0 to $9.0 million range

New cost reduction measures taking effect in Q4 2026 and Q1 2027: more reliance on in-house maintenance and less on contractors, certain roles consolidated and less reliance on temporary labor, outside services brought in-house or set to a routine level, logistics and storage sized to actual volumes, and on-site nitrogen supply in 2027

Project and growth spending is expected to be directionally lower in 2027 than in 2026, with a 2027 project spend range to be provided with fourth-quarter results

Net income of $6.9 million, including a $58.6 million non-cash gain on the change in fair value of warrants; Adjusted EBITDA of $(28.0) million, improved $0.6 million year over year

“The third quarter fell short of our plan. Operational issues in Q3 limited production, but we resolved them. New Jersey's extension of the food-contact exemption was a significant challenge, moving about 15 food-contact programs, roughly 50 million pounds of expected annual volume once fully ramped, out of the fourth quarter. Some of those brands are continuing on their own timetable and others have deferred. Two quick-service restaurant cup programs are progressing toward a 2027 ramp, and we have moved our primary sales and

marketing effort to non-food applications already in the pipeline, with initial positive results in October,” said Dustin Olson, Chief Executive Officer of PureCycle Technologies.

Olson continued, “Despite the NJ delay, the branded sales ramp is underway. This is a credit to our diverse pipeline and the flexibility of our product. P&G products are on shelves, railcars are moving to a large customer, a large global cosmetics company is expected to begin shipping this quarter, and a large global personal care company has approved our white grade. Including programs in contract negotiation or final qualification, we expect to approach the 40 to 50% utilization range once these programs fully ramp. On site compounding allows us to deliver the grade each customer specifies, which shortens the sales process. More of what decides our success is now within our control, and we are confident in the path ahead.”

“We ended the quarter with $193 million of liquidity and an undrawn $200 million revolver that matures in September 2028, and we are implementing cost efficiencies across the organization,” said Donald Carpenter, Chief Financial Officer of PureCycle Technologies. “Monthly operations spending was $7.8 million, below our guided range, and we will continue reducing costs into 2027. For several years our spending was sized to the challenges of learning to run a first-of-its-kind commercial plant, and the results of our cost reduction efforts should show in monthly operations spending. The Thailand incentives are in place, the construction permit was issued in September, significant capital has been invested, and we are negotiating the final terms of the project financing. We’ve reached internal milestones on growth projects, and discretionary spending is on hold while Ironton ramps.”

Separately today, the Company announced the appointment of Fernando Musa as Executive Chairman of the Board of Directors, effective November 3, 2026. Mr. Musa has served on PureCycle’s Board since 2021 and was its Lead Independent Director from 2021 to 2022. He served as Global Chief Executive Officer of Braskem S.A. from 2016 to 2019 and as Chief Executive Officer of Braskem America from 2012 to 2016, and he has advised private equity firms since 2020. His experience scaling polypropylene production and selling it to brands is directly relevant to the Ironton ramp. As Executive Chairman he will provide insight to the Company’s commercial and finance teams and assist management in executing its strategic objectives. Dan Coombs has stepped down as Chairman and will continue as a member of the Board. Dustin Olson continues as Chief Executive Officer.

Net income for Q3 2026 was $6.9 million, which included a $58.6 million non-cash gain on the change in fair value of warrants, compared to a net loss of $28.4 million in Q3 2025. Operating loss in Q3 2026 was $37.5 million compared to $38.9 million in Q3 2025. Adjusted EBITDA was $(28.0) million compared to $(28.6) million in Q3 2025, an improvement of $0.6 million.

Revenue was $2.3 million in Q3 2026, compared to $4.5 million in Q2 2026 and $2.4 million in Q3 2025, primarily reflecting operational issues in the quarter and the New Jersey delays. PureFive®production was 5.2 million pounds in Q3 2026 compared to 4.5 million pounds in Q2 2026 and 7.3 million pounds in Q3 2025.

PureCycle ended Q3 2026 with total liquidity of $193 million, which includes $109 million in cash and cash equivalents, $71.4 million invested in marketable securities and $12.6 million in restricted cash, compared to $236.9 million at the end of Q2 2026. Including the undrawn $200 million revolving credit facility, total available liquidity was $393 million at the end of Q3.

The Company identified cost reductions, with new measures in effect in Q4 2026 and Q1 2027, and expects to continue reducing costs into 2027. The equipment financing payments concluded in September 2026.

Project spend in Q3 2026 totaled $13.0 million, bringing project spend for the first nine months of 2026 to $47.6 million. The Company expects fourth-quarter project spend of approximately $4 million, mainly committed costs of its other projects, and full-year project spend of approximately $51 million, compared with the full-year range of $45 to $50 million provided in August. Project and growth spending is expected to be directionally lower in 2027 than in 2026. Expected project spend in Q4 2026 and 2027 depends on the timing of the Thailand financing, and the Company will provide a 2027 range with its fourth-quarter results.

The Company's capital structure is unchanged from the June 2026 refinancing other than the August 2026 extension of the maturity of its $200 million revolving credit facility to September 30, 2028. That facility remains undrawn.

Fourth-quarter 2026 debt service is expected to be approximately $9.4 million, mainly the December 1, 2026 revenue bond payment. The first coupon on the 4.75% senior convertible notes is payable in January 2027. Equipment financing payments concluded in September 2026.

The Company's available capital resources are cash, marketable securities and the undrawn $200 million revolving credit facility. Potential future sources of capital, which the Company does not assume in its liquidity planning, are approximately $76 million of revenue bonds held by the Company, equipment financing on owned PreP equipment ($67.3 million original cost) and approximately $272 million of proceeds if the warrants expiring in March 2027 are exercised at $11.50.

For participants interested in a listen-only webcast, please access the conference call using the above link. For a calendar reminder, please clickHERE.

The conference call will have a live Q&A session. For analyst participants who would like to ask management a question after prepared remarks, please clickHERE. You will receive a number and a unique access pin.

Following prepared remarks, management will try to answer investor questions submitted in advance. To submit a question, please send an e-mail [email protected].

The corporate update will be available for replay by clickingHEREor through the Company’s website atwww.purecycle.com. A replay of the conference call will be available after 8:00 p.m. ET until February 4, 2027.

The date of the Company's fourth-quarter 2026 results call will be announced separately.

PureCycle Technologies LLC, a subsidiary of PureCycle Technologies, Inc., holds a global license for the only patented dissolution recycling technology, developed by The Procter & Gamble Company (P&G), that is designed to transform polypropylene plastic waste (designated as #5 plastic) into a continuously renewable resource. The unique purification process removes color, odor, and other impurities from #5 plastic waste resulting in our PureFive®resin that can be recycled and reused multiple times, changing our relationship with plastic.www.purecycle.com

This press release contains forward-looking statements, including statements about the continued execution of PureCycle’s business plan, PureCycle expected financial expenditures, future cash needs and availability of liquidity and the expected timing of significant construction milestones for PureCycle’s planned future facilities. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward- looking statements generally relate to future events or PureCycle’s future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are often identified by future or conditional words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current expectations of PureCycle’s management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section entitled “Risk Factors” in each of PureCycle’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and PureCycle’s Quarterly Reports on Form 10-Q for various quarterly periods, those discussed and identified in other public filings made with the Securities and Exchange Commission by PureCycle and the following: PCT’s ability to obtain funding for its operations, future capital requirements and future growth, and to continue as a going concern; PCT’s ability to meet, continue to meet, and comply on an ongoing basis with, the numerous regulatory requirements applicable to its PureFive®resin both generally and in food-grade applications and, more broadly, the operations and construction of PCT’s facilities (including in the United States, Europe, Asia and other future international locations); expectations and changes regarding PCT’s strategies and future financial performance, including future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and PCT’s ability to invest in growth initiatives, which could be impacted by significant changes to tariffs on foreign imports; the ability of PCT’s first commercial-scale recycling facility in Lawrence County, Ohio (the “Ironton Facility”) to be appropriately certified by Leidos Engineering, LLC, following certain performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner, or at all; PCT’s ability to meet, and to continue to meet, the requirements imposed upon us and our subsidiaries by the funding

for its operations, including the funding for the Ironton Facility and the Planned Facilities (as defined below); PCT’s ability to minimize or eliminate the many hazards and operational risks at its manufacturing facilities that can result in potential injury to individuals, disrupt PCT’s business, including interruptions or disruptions in operations at PCT’s facilities, and subject PCT to liability and increased costs; PCT’s ability to complete the necessary funding with respect to, and complete the construction of, the new polypropylene recycling facility in Thailand (the "Thailand Facility"), PCT’s first commercial-scale European plant located in Antwerp, Belgium (the "Belgium Facility"), and the purification facility to be built in Augusta, Georgia (the "Augusta Facility" and, together with the Thailand Facility and the Belgium Facility, the “Planned Facilities”) in a timely and cost-effective manner; PCT’s ability to procure, sort and process polypropylene plastic waste at our planned plastic waste prep facilities; PCT’s ability to maintain exclusivity under The Procter & Gamble Company license; the implementation, market acceptance and success of PCT’s business model and growth strategy, which includes PCT’s ability to bring a total of one billion pounds of installed polypropylene recycling capability online in the future, and PCT’s ability to meet related construction, regulatory, and financing requirements; the ability to negotiate multi-year offtake agreements at appropriate margins to fund ongoing operations; the possibility that PCT may be adversely affected or potentially impacted by economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, regulatory developments, and other macro-economic impacts (such as tariffs); changes in the prices and availability of materials (such as steel and other materials needed for the construction of future Feed PreP and purification facilities), including those changes caused by inflation, tariffs and supply chain conditions, such as increased transportation costs and global conflicts, and our ability to obtain such materials in a timely and cost-effective manner; the ability to source feedstock with a high polypropylene content at a reasonable cost and the temporary spike in prices due to global conflicts such as the current conflicts in the Middle East and between Russia and Ukraine; the development of direct competitors in the recycled polypropylene segment that could impact the demand for PCT’s products; the outcome of any legal or regulatory proceedings to which PCT is, or may become, a party; geopolitical risk and changes in applicable laws or regulations; changes in the prices and availability of labor (including labor shortages), turnover in employees, and increases in employee-related costs; any business disruptions due to political or economic instability, pandemics, or armed hostilities (including the ongoing conflicts between Russia and Ukraine and active military conflicts in the Middle East); and operational risks associated with the ability to operate the Ironton Facility and the Planned Facilities, as and when operative, at nameplate capacity.

PCT undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Should one or more of these risks or uncertainties materialize or should any of the assumptions made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. – financial tables attached – PureCycle Technologies, Inc. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) (Unaudited)

September 30, December 31, (in thousands) 2026 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS CURRENT ASSETS Cash and cash $ 109,041 $ 156,694 equivalents Available-fo… 71,369 13,631 investments Restricted 3,147 1,984 cash, current Accounts receivable, 4,140 2,007 net Inventory 20,212 13,824 Prepaid expenses and 9,657 9,877 other current assets Total current 217,566 198,017 assets NONCURRENT ASSETS Restricted cash, 9,481 9,356 noncurrent Operating lease 64,415 54,226 right-of-use assets Property, plant and 662,032 657,752 equipment, net Prepaid expenses and other 2,965 3,315 noncurrent assets TOTAL ASSETS $ 956,459 $ 922,666 LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts $ 9,956 $ 9,247 payable Accrued expenses and 21,415 42,815 other current liabilities Accrued 7,947 7,805 interest Current portion of 13,327 13,682 warrant liability Current portion of 33,723 6,446 long-term debt Current portion of related party 7,830 7,570 bonds payable Series A Preferred Stock 42,159 — liability, current Total current 136,357 87,565 liabilities NONCURRENT LIABILITIES Deferred 5,000 5,000 revenue Long-term debt, less 310,133 263,355 current portion Related party bonds payable, less 83,701 86,343 current portion Warrant liability, 16,446 45,149 less current portion Operating lease 62,418 52,350 right-of-use liabilities Series A Preferred — 29,606 Stock liability Other noncurrent 2,697 2,710 liabilities TOTAL 616,752 572,078 LIABILITIES MEZZANINE EQUITY Series B Convertible Perpetual 321,213 304,701 Preferred Stock STOCKHOLDERS' EQUITY Common Stock 201 180 Additional paid-in 1,003,680 861,953 capital Accumulated other (654 ) (305 ) comprehensive loss Accumulated (984,733 ) (815,941 ) deficit TOTAL STOCKHOLDERS' 18,494 45,887 EQUITY TOTAL LIABILITIES, MEZZANINE $ 956,459 $ 922,666 EQUITY, AND STOCKHOLDERS’ EQUITY

PureCycle Technologies, Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands) Cash flows from Nine Months Ended operating September 30, activities 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net loss $ (168,792 ) $ (163,778 ) Adjustments to reconcile net loss to net cash used in operating activities Equity-based 6,609 12,668 compensation Change in fair (29,058 ) 1,881 value of warrants Change in fair value of put 2,256 (3,443 ) option Depreciation 22,200 21,875 expense Loss on disposal 426 3,765 of equipment Amortization of debt issuance 19,804 17,335 costs and debt discounts Loss on extinguishment of 34,541 — debt Operating lease amortization 3,639 3,398 expense Other (439 ) 938 Changes in operating assets and liabilities Accounts (2,133 ) (1,595 ) receivable, net Inventory (6,388 ) (3,539 ) Prepaid expenses and other current 30 (878 ) assets Prepaid expenses and other 350 968 noncurrent assets Accounts payable 634 (2,062 ) Accrued expenses and other current (8,783 ) (578 ) liabilities Accrued interest 3,387 1,820 Operating lease right-of-use (3,247 ) (2,827 ) liabilities Net cash used in operating (124,964 ) (114,052 ) activities Cash flows from investing activities Purchase of property, plant (42,039 ) (27,504 ) and equipment Purchase of debt securities, (125,705 ) — available for sale Sale and maturity of 68,134 — available-for-sale investments Net cash used in investing (99,610 ) (27,504 ) activities Cash flows from financing activities Proceeds from issuance of Series B — 300,000 Convertible Perpetual Preferred Stock Proceeds from issuance of Common 163,006 33,462 Stock Proceeds from issuance of 287,500 — Convertible Senior Notes Repurchase of Green Convertible (241,079 ) — Notes Proceeds from issuance of — 16,808 revenue bonds to third parties Proceeds from issuance of — 10,063 revenue bonds to related parties Payments on related party (3,720 ) (535 ) revenue bonds Proceeds from revolving credit facility — 14,900 and related party note payable Payments on revolving credit facility — (14,900 ) and related party note payable Proceeds from exercise and 243 6,616 issuance of warrants Payments on equipment (4,027 ) (7,663 ) financing Stock and debt (19,577 ) (7,624 ) issuance costs Payments to (2,797 ) (4,527 ) repurchase shares Other financing (1,340 ) 698 activities Net cash provided by financing 178,209 347,298 activities Net (decrease)/increa… (46,365 ) 205,742 in cash and restricted cash Cash and cash equivalents and restricted 168,034 41,511 cash, beginning of period Cash and cash equivalents and restricted $ 121,669 $ 247,253 cash, end of period

The Company uses certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (“GAAP”) to supplement its financial statements. These non-GAAP financial measures provide additional information to investors to facilitate comparisons of past and present operating results, identify trends in our underlying operating performance, and offer greater transparency on how the Company evaluates its business activities. These measures are integral to the Company’s process for budgeting, managing operations, making strategic decisions and evaluating its performance.

The Company’s primary non-GAAP financial measures are EBITDA and Adjusted EBITDA. The Company defines EBITDA as net income before interest expense, interest income, taxes and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted to exclude certain non-cash items and other items that are not indicative of the Company’s core operating activities. These may include equity-based compensation expense and changes in the fair value of warrants and put options, and other financial items. The Company believes Adjusted EBITDA is valuable for investors and analysts as it provides additional insight into the Company’s operational performance, excluding the impacts of certain financing, investing, and other non-operational activities. This measure helps in comparing the Company’s current operating results with prior periods and with those of other companies in the Company’s industry. It is also used internally for allocating resources efficiently, assessing strategic decisions, and evaluating the performance of the Company’s management team.

There are limitations to Adjusted EBITDA, including its exclusion of cash expenditures, future requirements for capital expenditures and contractual commitments, and changes in the Company’s cash requirements for working capital needs. Adjusted EBITDA also omits significant interest expense and related cash requirements for interest and payments. While depreciation and amortization are non-cash charges, the associated assets will often need to be replaced in the future, and Adjusted EBITDA does not reflect the cash required for such replacements. Additionally, Adjusted EBITDA does not account for income or other taxes or necessary cash tax payments.

Investors should use caution when comparing the Company’s non-GAAP measure to similar metrics used by other companies, as definitions can vary. Neither EBITDA nor Adjusted EBITDA should be considered in isolation or as a substitute for GAAP financial measures. In presenting EBITDA and Adjusted EBITDA, the Company aims to provide investors with an additional tool for assessing the operational performance of the Company’s business. It serves as a useful complement to the Company’s GAAP results, offering a more comprehensive understanding of the Company’s financial health and operational efficiencies. The table at the end of the press release provides a reconciliation from Net Income (Loss) to Adjusted EBITDA for the specified periods. The following table reconciles GAAP net income (loss) to Adjusted EBITDA (in thousands):

Q3 2026 Q2 2026 Q3 2025 Consolidated Revenue ($MM) $2.3 $4.5 $2.4 Monthly Ops. Spending ($MM)* $7.8 $8.4 $8.3 Ironton Purification PureFive® Production (MM lbs) 5.2 4.5 7.3 Other Production (MM lbs) 0.9 0.1 0.6 Feedstock Processed (MM lbs) 5.8 5.0 8.1

Other Production includes co-products and other saleable volumes, net of reprocessed material. *Monthly operations spending is the average monthly cash spend on operations and corporate costs, excluding materials purchases, turnaround costs (in project spend), and severance and other costs to implement the savings measures. All periods are on the same basis, with Q2 2026 restated to include equipment lease payments ($8.3 million per month as previously reported). ###

Full text with the tables
                                                                    Exhibit 99.1
                                                                                
           PureCycle Technologies Reports Third Quarter 2026 Results            
                                                                                
Branded programs shipping, under purchase order, in contract negotiation, or    
final qualification are expected to reach approximately 45-55 million pounds per
year at full ramp, which would approach the 40 to 50% utilization range         
                                                                                
P&G products are on shelves; railcar shipments began in October to a large      
customer for hot lids; and resin is qualified for shampoo closures at a large   
global cosmetics company with shipments expected in Q4                          
                                                                                
Ironton produced 5.2 million pounds of PureFive ® resin in Q3, up 14%           
sequentially; operational issues in Q3 limited production and were resolved;    
production is now in line with current commercial demand                        
                                                                                
Thailand construction permit issued; final terms of the project financing under 
negotiation                                                                     
                                                                                
Third quarter average monthly operations spending below the guided range        
                                                                                
ORLANDO, FLA., November 4, 2026—PureCycle Technologies, Inc.(Nasdaq: PCT)       
(“PureCycle” or the “Company”), a U.S.-based company revolutionizing plastic    
recycling, today announced results for the third quarter ended September 30,    
2026.                                                                           
                                                                                
Third Quarter 2026 Highlights                                                   
                                                                                
Commercial                                                                      
                                                                                
Railcar shipments started in October to a large customer for hot lids,          
representing a program of approximately 7–8 million pounds of expected annual   
volume once fully ramped                                                        
                                                                                
Procter & Gamble (P&G) products are on shelves, including Downy and Tide caps,  
with first Tide deliveries in October; Gain caps are a new application and      
another brand color the Company has matched; Vicks ZzzQuil lids are in          
commercial production                                                           
                                                                                
Resin shipments to a large global cosmetics company are expected to begin in Q4 
for shampoo closures with 100% recycled content, and a large global personal    
care company has approved a white grade for deodorant sticks, with the final    
trial this month                                                                
                                                                                
Two major quick-service restaurant cold-cup programs are qualified; launches    
planned for 2026 moved to 2027 following the New Jersey exemption extension;    
term sheet conditions are agreed upon, and the supply agreement is under        
negotiation                                                                     
                                                                                
New Jersey's extension of its food-contact exemption shifted about 15 food-     
contact programs, approximately 50 million pounds of expected annual volume once
fully ramped, into 2027 and in many cases beyond. The Company has moved its     
primary sales and marketing effort to non-food applications, where the January  
2027 compliance date still applies, with initial positive results in October    
                                                                                
Q3 revenue of $2.3 million primarily reflects operational issues in the quarter 
and the New Jersey delays; strong branded customer and purchase-order momentum  
in October                                                                      
                                                                                
Operations                                                                      
                                                                                
Ironton produced 5.2 million pounds of PureFive ® resin in Q3, up 14% from Q2   
                                                                                
Operational issues in Q3 limited production and were resolved                   
                                                                                
Production is now in line with current commercial demand; as programs convert,  
the priority is supplying each customer consistently to its specification, so   
production is designed to rise with shipments                                   
                                                                                
On-site compounding transitioned to 24/7 availability and is accelerating many  
customer programs, with more than 20 grades formulated in-house to meet         
customers’ specifications                                                       
                                                                                
The Company continued to make incremental improvements at Ironton to reduce     
costs and raise operating efficiency                                            
                                                                                
Long-term feedstock agreement with WM, the largest recycler in North America,   
for up to 25 million pounds per year of waste polypropylene bales over three    
years beginning November 2026; the two companies are also continuing to work    
together on circularity programs with brands                                    
                                                                                
Growth                                                                          
                                                                                
The construction permit for the Rayong site was issued in September;            
groundbreaking will be scheduled once the timing of financial close is clear;   
total project cost estimate remains in the $250 million range                   
                                                                                
Final terms and conditions of the Thailand project financing are under          
negotiation                                                                     
                                                                                
The Company has invested more than $85 million in equipment and engineering for 
the Rayong, Thailand project to date                                            
                                                                                
Growth projects have reached internal milestones; discretionary spending is on  
hold until commercial progress at Ironton supports further investment           
                                                                                
Finance                                                                         
                                                                                
Total liquidity of $193 million at quarter-end, consisting of cash and cash     
equivalents, marketable securities and restricted cash, plus the undrawn $200   
million revolving credit facility, now extended to September 30, 2028, for total
available liquidity of $393 million                                             
                                                                                
Monthly operations spending of $7.8 million in Q3, excluding materials purchases
of approximately $2.7 million per month, below the Company's previously guided  
$8.0 to $9.0 million range                                                      
                                                                                
New cost reduction measures taking effect in Q4 2026 and Q1 2027: more reliance 
on in-house maintenance and less on contractors, certain roles consolidated and 
less reliance on temporary labor, outside services brought in-house or set to a 
routine level, logistics and storage sized to actual volumes, and on-site       
nitrogen supply in 2027                                                         
                                                                                
Project and growth spending is expected to be directionally lower in 2027 than  
in 2026, with a 2027 project spend range to be provided with fourth-quarter     
results                                                                         
                                                                                
Net income of $6.9 million, including a $58.6 million non-cash gain on the      
change in fair value of warrants; Adjusted EBITDA of $(28.0) million, improved  
$0.6 million year over year                                                     
                                                                                
   Management Commentary                                                        
                                                                                
“The third quarter fell short of our plan. Operational issues in Q3 limited     
production, but we resolved them. New Jersey's extension of the food-contact    
exemption was a significant challenge, moving about 15 food-contact programs,   
roughly 50 million pounds of expected annual volume once fully ramped, out of   
the fourth quarter. Some of those brands are continuing on their own timetable  
and others have deferred. Two quick-service restaurant cup programs are         
progressing toward a 2027 ramp, and we have moved our primary sales and         
                                                                                
marketing effort to non-food applications already in the pipeline, with initial 
positive results in October,” said Dustin Olson, Chief Executive Officer of     
PureCycle Technologies.                                                         
                                                                                
Olson continued, “Despite the NJ delay, the branded sales ramp is underway. This
is a credit to our diverse pipeline and the flexibility of our product. P&G     
products are on shelves, railcars are moving to a large customer, a large global
cosmetics company is expected to begin shipping this quarter, and a large global
personal care company has approved our white grade. Including programs in       
contract negotiation or final qualification, we expect to approach the 40 to 50%
utilization range once these programs fully ramp. On site compounding allows us 
to deliver the grade each customer specifies, which shortens the sales process. 
More of what decides our success is now within our control, and we are confident
in the path ahead.”                                                             
                                                                                
“We ended the quarter with $193 million of liquidity and an undrawn $200 million
revolver that matures in September 2028, and we are implementing cost           
efficiencies across the organization,” said Donald Carpenter, Chief Financial   
Officer of PureCycle Technologies. “Monthly operations spending was $7.8        
million, below our guided range, and we will continue reducing costs into 2027. 
For several years our spending was sized to the challenges of learning to run a 
first-of-its-kind commercial plant, and the results of our cost reduction       
efforts should show in monthly operations spending. The Thailand incentives are 
in place, the construction permit was issued in September, significant capital  
has been invested, and we are negotiating the final terms of the project        
financing. We’ve reached internal milestones on growth projects, and            
discretionary spending is on hold while Ironton ramps.”                         
                                                                                
Board Update                                                                    
                                                                                
Separately today, the Company announced the appointment of Fernando Musa as     
Executive Chairman of the Board of Directors, effective November 3, 2026. Mr.   
Musa has served on PureCycle’s Board since 2021 and was its Lead Independent    
Director from 2021 to 2022. He served as Global Chief Executive Officer of      
Braskem S.A. from 2016 to 2019 and as Chief Executive Officer of Braskem America
from 2012 to 2016, and he has advised private equity firms since 2020. His      
experience scaling polypropylene production and selling it to brands is directly
relevant to the Ironton ramp. As Executive Chairman he will provide insight to  
the Company’s commercial and finance teams and assist management in executing   
its strategic objectives. Dan Coombs has stepped down as Chairman and will      
continue as a member of the Board. Dustin Olson continues as Chief Executive    
Officer.                                                                        
                                                                                
   Financial Update                                                             
                                                                                
Financial Results                                                               
                                                                                
Net income for Q3 2026 was $6.9 million, which included a $58.6 million non-cash
gain on the change in fair value of warrants, compared to a net loss of $28.4   
million in Q3 2025. Operating loss in Q3 2026 was $37.5 million compared to     
$38.9 million in Q3 2025. Adjusted EBITDA was $(28.0) million compared to       
$(28.6) million in Q3 2025, an improvement of $0.6 million.                     
                                                                                
Revenue was $2.3 million in Q3 2026, compared to $4.5 million in Q2 2026 and    
$2.4 million in Q3 2025, primarily reflecting operational issues in the quarter 
and the New Jersey delays. PureFive®production was 5.2 million pounds in Q3 2026
compared to 4.5 million pounds in Q2 2026 and 7.3 million pounds in Q3 2025.    
                                                                                
Cash and Liquidity                                                              
                                                                                
PureCycle ended Q3 2026 with total liquidity of $193 million, which includes    
$109 million in cash and cash equivalents, $71.4 million invested in marketable 
securities and $12.6 million in restricted cash, compared to $236.9 million at  
the end of Q2 2026. Including the undrawn $200 million revolving credit         
facility, total available liquidity was $393 million at the end of Q3.          
                                                                                
The Company identified cost reductions, with new measures in effect in Q4 2026  
and Q1 2027, and expects to continue reducing costs into 2027. The equipment    
financing payments concluded in September 2026.                                 
                                                                                
Project Spend                                                                   
                                                                                
Project spend in Q3 2026 totaled $13.0 million, bringing project spend for the  
first nine months of 2026 to $47.6 million. The Company expects fourth-quarter  
project spend of approximately $4 million, mainly committed costs of its other  
projects, and full-year project spend of approximately $51 million, compared    
with the full-year range of $45 to $50 million provided in August. Project and  
growth spending is expected to be directionally lower in 2027 than in 2026.     
Expected project spend in Q4 2026 and 2027 depends on the timing of the Thailand
financing, and the Company will provide a 2027 range with its fourth-quarter    
results.                                                                        
                                                                                
Capital Structure                                                               
                                                                                
The Company's capital structure is unchanged from the June 2026 refinancing     
other than the August 2026 extension of the maturity of its $200 million        
revolving credit facility to September 30, 2028. That facility remains undrawn. 
                                                                                
Fourth-quarter 2026 debt service is expected to be approximately $9.4 million,  
mainly the December 1, 2026 revenue bond payment. The first coupon on the 4.75% 
senior convertible notes is payable in January 2027. Equipment financing        
payments concluded in September 2026.                                           
                                                                                
The Company's available capital resources are cash, marketable securities and   
the undrawn $200 million revolving credit facility. Potential future sources of 
capital, which the Company does not assume in its liquidity planning, are       
approximately $76 million of revenue bonds held by the Company, equipment       
financing on owned PreP equipment ($67.3 million original cost) and             
approximately $272 million of proceeds if the warrants expiring in March 2027   
are exercised at $11.50.                                                        
                                                                                
Third Quarter 2026 Conference Call Details                                      
                                                                                
Date: November 4, 2026                                                          
Time: 5:00 p.m. ET                                                              
                                                                                
Participant Link:PureCycle Technologies Third Quarter 2026 Corporate Update     
                                                                                
For participants interested in a listen-only webcast, please access the         
conference call using the above link. For a calendar reminder, please clickHERE.
                                                                                
The conference call will have a live Q&A session. For analyst participants who  
would like to ask management a question after prepared remarks, please          
clickHERE. You will receive a number and a unique access pin.                   
                                                                                
Following prepared remarks, management will try to answer investor questions    
submitted in advance. To submit a question, please send an e-mail               
[email protected].                                               
                                                                                
The corporate update will be available for replay by clickingHEREor through the 
Company’s website atwww.purecycle.com. A replay of the conference call will be  
available after 8:00 p.m. ET until February 4, 2027.                            
                                                                                
The date of the Company's fourth-quarter 2026 results call will be announced    
separately.                                                                     
                                                                                
PureCycle Contact                                                               
                                                                                
Christian Bruey                                                                 
                                                                                
[email protected]                                                            
                                                                                
Investor Relations Contact                                                      
                                                                                
Eric DeNatale                                                                   
                                                                                
[email protected]                                                         
                                                                                
About PureCycle Technologies                                                    
                                                                                
PureCycle Technologies LLC, a subsidiary of PureCycle Technologies, Inc., holds 
a global license for the only patented dissolution recycling technology,        
developed by The Procter & Gamble Company (P&G), that is designed to transform  
polypropylene plastic waste (designated as #5 plastic) into a continuously      
renewable resource. The unique purification process removes color, odor, and    
other impurities from #5 plastic waste resulting in our PureFive®resin that can 
be recycled and reused multiple times, changing our relationship with           
plastic.www.purecycle.com                                                       
                                                                                
Forward Looking Statements                                                      
                                                                                
This press release contains forward-looking statements, including statements    
about the continued execution of PureCycle’s business plan, PureCycle expected  
financial expenditures, future cash needs and availability of liquidity and the 
expected timing of significant construction milestones for PureCycle’s planned  
future facilities. In addition, any statements that refer to projections,       
forecasts or other characterizations of future events or circumstances,         
including any underlying assumptions, are forward-looking statements. Forward-  
looking statements generally relate to future events or PureCycle’s future      
financial or operating performance and may refer to projections and forecasts.  
Forward-looking statements are often identified by future or conditional words  
such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,”         
“estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,”         
“possible,” “potential,” “predict,” “should,” “would” and other similar words   
and expressions (or the negative versions of such words or expressions), but the
absence of these words does not mean that a statement is not forward-looking.   
                                                                                
The forward-looking statements are based on the current expectations of         
PureCycle’s management and are inherently subject to uncertainties and changes  
in circumstances and their potential effects and speak only as of the date of   
this press release. There can be no assurance that future developments will be  
those that have been anticipated. These forward-looking statements involve a    
number of risks, uncertainties or other assumptions that may cause actual       
results or performance to be materially different from those expressed or       
implied by these forward-looking statements. These risks and uncertainties      
include, but are not limited to, those factors described in the section entitled
“Risk Factors” in each of PureCycle’s Annual Report on Form 10-K for the fiscal 
year ended December 31, 2025 and PureCycle’s Quarterly Reports on Form 10-Q for 
various quarterly periods, those discussed and identified in other public       
filings made with the Securities and Exchange Commission by PureCycle and the   
following: PCT’s ability to obtain funding for its operations, future capital   
requirements and future growth, and to continue as a going concern; PCT’s       
ability to meet, continue to meet, and comply on an ongoing basis with, the     
numerous regulatory requirements applicable to its PureFive®resin both generally
and in food-grade applications and, more broadly, the operations and            
construction of PCT’s facilities (including in the United States, Europe, Asia  
and other future international locations); expectations and changes regarding   
PCT’s strategies and future financial performance, including future business    
plans, expansion plans or objectives, prospective performance and opportunities 
and competitors, revenues, products and services, pricing, operating expenses,  
market trends, liquidity, cash flows and uses of cash, capital expenditures, and
PCT’s ability to invest in growth initiatives, which could be impacted by       
significant changes to tariffs on foreign imports; the ability of PCT’s first   
commercial-scale recycling facility in Lawrence County, Ohio (the “Ironton      
Facility”) to be appropriately certified by Leidos Engineering, LLC, following  
certain performance and other tests, and commence full-scale commercial         
operations in a timely and cost-effective manner, or at all; PCT’s ability to   
meet, and to continue to meet, the requirements imposed upon us and our         
subsidiaries by the funding                                                     
                                                                                
for its operations, including the funding for the Ironton Facility and the      
Planned Facilities (as defined below); PCT’s ability to minimize or eliminate   
the many hazards and operational risks at its manufacturing facilities that can 
result in potential injury to individuals, disrupt PCT’s business, including    
interruptions or disruptions in operations at PCT’s facilities, and subject PCT 
to liability and increased costs; PCT’s ability to complete the necessary       
funding with respect to, and complete the construction of, the new polypropylene
recycling facility in Thailand (the "Thailand Facility"), PCT’s first           
commercial-scale European plant located in Antwerp, Belgium (the "Belgium       
Facility"), and the purification facility to be built in Augusta, Georgia (the  
"Augusta Facility" and, together with the Thailand Facility and the Belgium     
Facility, the “Planned Facilities”) in a timely and cost-effective manner; PCT’s
ability to procure, sort and process polypropylene plastic waste at our planned 
plastic waste prep facilities; PCT’s ability to maintain exclusivity under The  
Procter & Gamble Company license; the implementation, market acceptance and     
success of PCT’s business model and growth strategy, which includes PCT’s       
ability to bring a total of one billion pounds of installed polypropylene       
recycling capability online in the future, and PCT’s ability to meet related    
construction, regulatory, and financing requirements; the ability to negotiate  
multi-year offtake agreements at appropriate margins to fund ongoing operations;
the possibility that PCT may be adversely affected or potentially impacted by   
economic, business, and/or competitive factors, including interest rates,       
availability of capital, economic cycles, regulatory developments, and other    
macro-economic impacts (such as tariffs); changes in the prices and availability
of materials (such as steel and other materials needed for the construction of  
future Feed PreP and purification facilities), including those changes caused by
inflation, tariffs and supply chain conditions, such as increased transportation
costs and global conflicts, and our ability to obtain such materials in a timely
and cost-effective manner; the ability to source feedstock with a high          
polypropylene content at a reasonable cost and the temporary spike in prices due
to global conflicts such as the current conflicts in the Middle East and between
Russia and Ukraine; the development of direct competitors in the recycled       
polypropylene segment that could impact the demand for PCT’s products; the      
outcome of any legal or regulatory proceedings to which PCT is, or may become, a
party; geopolitical risk and changes in applicable laws or regulations; changes 
in the prices and availability of labor (including labor shortages), turnover in
employees, and increases in employee-related costs; any business disruptions due
to political or economic instability, pandemics, or armed hostilities (including
the ongoing conflicts between Russia and Ukraine and active military conflicts  
in the Middle East); and operational risks associated with the ability to       
operate the Ironton Facility and the Planned Facilities, as and when operative, 
at nameplate capacity.                                                          
                                                                                
PCT undertakes no obligation to update any forward-looking statements made in   
this press release to reflect events or circumstances after the date of this    
press release or to reflect new information or the occurrence of unanticipated  
events, except as required by law.                                              
Should one or more of these risks or uncertainties materialize or should any of 
the assumptions made prove incorrect, actual results may vary in material       
respects from those projected in these forward-looking statements. You should   
not rely upon forward-looking statements as predictions of future events.       
                         – financial tables attached –                          
PureCycle Technologies, Inc. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME/(LOSS) (Unaudited)
                                                                                
  (in                                                                           
  tho…          Three                                Nine                       
  exc…          Mont…                               Mont…                       
  per           Ended                               Ended                       
  sha…          Sept…                               Sept…                       
  dat…    2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Rev…    $     2,349       $     2,430       $     10,9…       $     5,660     
  Ope…                                                                          
  exp…                                                                          
  Cost                                                                          
  of            30,7…             27,2…             96,9…             81,2…     
  ope…                                                                          
  Res…                                                                          
  and           1,265             1,471             4,234             4,432     
  dev…                                                                          
  Sel…                                                                          
  gen…          7,781             12,6…             30,3…             42,2…     
  and                                                                           
  adm…                                                                          
  Tot…                                                                          
  ope…                                                                          
  cos…          39,8…             41,3…             131,…             127,…     
  and                                                                           
  exp…                                                                          
  Ope…          (37,…  )          (38,…  )          (120…  )          (122…  )  
  loss                                                                          
  Oth…                                                                          
  exp…                                                                          
  Int…          14,7…             16,2…             45,5…             48,9…     
  exp…                                                                          
  Int…          (1,9…  )          (2,8…  )          (4,3…  )          (3,8…  )  
  inc…                                                                          
  Cha…                                                                          
  in                                                                            
  fair          (58,…  )          (23,…  )          (29,…  )          1,881     
  val…                                                                          
  of                                                                            
  war…                                                                          
  Loss                                                                          
  on                                                                            
  ext…              —                 —             34,5…                 —     
  of                                                                            
  debt                                                                          
  Oth…                                                                          
  exp…          1,432              (203  )          1,526             (5,4…  )  
  net                                                                           
  Tot…                                                                          
  oth…          (44,…  )          (10,…  )          48,2…             41,5…     
  (in…                                                                          
  Net     $     6,868       $     (28,…  )    $     (168…  )    $     (163…  )  
  inc…                                                                          
  Net                                                                           
  inc…                                                                          
  per                                                                           
  sha…                                                                          
  Bas…    $      0.00       $     (0.19  )    $     (0.98  )    $     (0.95  )  
  Dil…    $      0.00       $     (0.31  )    $     (0.98  )    $     (1.07  )  
  Wei…                                                                          
  ave…                                                                          
  com…                                                                          
  sha…                                                                          
  Bas…          200,…             180,…             188,…             179,…     
  Dil…          201,…             184,…             188,…             180,…     
  Oth…                                                                          
  com…                                                                          
  loss                                                                          
  Cum…                                                                          
  tra…    $        (6  )    $       (20  )    $      (314  )    $      (329  )  
  adj…                                                                          
  Unr…                                                                          
  loss                                                                          
  on              (16  )              —               (35  )              —     
  ava…                                                                          
  inv…                                                                          
  Tot…                                                                          
  com…    $     6,846       $     (28,…  )    $     (169…  )    $     (164…  )  
  inc…                                                                          
                                                                                
PureCycle Technologies, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
                                                                                
                                      September 30,            December 31,     
                 (in thousands)                2026                    2025     
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  CURRENT                                                                       
  ASSETS                                                                        
  Cash and cash                  $          109,041       $         156,694     
  equivalents                                                                   
  Available-fo…                              71,369                  13,631     
  investments                                                                   
  Restricted                                  3,147                   1,984     
  cash, current                                                                 
  Accounts                                                                      
  receivable,                                 4,140                   2,007     
  net                                                                           
  Inventory                                  20,212                  13,824     
  Prepaid                                                                       
  expenses and                                9,657                   9,877     
  other current                                                                 
  assets                                                                        
  Total current                             217,566                 198,017     
  assets                                                                        
  NONCURRENT                                                                    
  ASSETS                                                                        
  Restricted                                                                    
  cash,                                       9,481                   9,356     
  noncurrent                                                                    
  Operating                                                                     
  lease                                      64,415                  54,226     
  right-of-use                                                                  
  assets                                                                        
  Property,                                                                     
  plant and                                 662,032                 657,752     
  equipment,                                                                    
  net                                                                           
  Prepaid                                                                       
  expenses and                                                                  
  other                                       2,965                   3,315     
  noncurrent                                                                    
  assets                                                                        
  TOTAL ASSETS                   $          956,459       $         922,666     
  LIABILITIES,                                                                  
  MEZZANINE                                                                     
  EQUITY, AND                                                                   
  STOCKHOLDERS’                                                                 
  EQUITY                                                                        
  CURRENT                                                                       
  LIABILITIES                                                                   
  Accounts                       $            9,956       $           9,247     
  payable                                                                       
  Accrued                                                                       
  expenses and                               21,415                  42,815     
  other current                                                                 
  liabilities                                                                   
  Accrued                                     7,947                   7,805     
  interest                                                                      
  Current                                                                       
  portion of                                 13,327                  13,682     
  warrant                                                                       
  liability                                                                     
  Current                                                                       
  portion of                                 33,723                   6,446     
  long-term                                                                     
  debt                                                                          
  Current                                                                       
  portion of                                                                    
  related party                               7,830                   7,570     
  bonds                                                                         
  payable                                                                       
  Series A                                                                      
  Preferred                                                                     
  Stock                                      42,159                       —     
  liability,                                                                    
  current                                                                       
  Total current                             136,357                  87,565     
  liabilities                                                                   
  NONCURRENT                                                                    
  LIABILITIES                                                                   
  Deferred                                    5,000                   5,000     
  revenue                                                                       
  Long-term                                                                     
  debt, less                                310,133                 263,355     
  current                                                                       
  portion                                                                       
  Related party                                                                 
  bonds                                                                         
  payable, less                              83,701                  86,343     
  current                                                                       
  portion                                                                       
  Warrant                                                                       
  liability,                                 16,446                  45,149     
  less current                                                                  
  portion                                                                       
  Operating                                                                     
  lease                                      62,418                  52,350     
  right-of-use                                                                  
  liabilities                                                                   
  Series A                                                                      
  Preferred                                       —                  29,606     
  Stock                                                                         
  liability                                                                     
  Other                                                                         
  noncurrent                                  2,697                   2,710     
  liabilities                                                                   
  TOTAL                                     616,752                 572,078     
  LIABILITIES                                                                   
  MEZZANINE                                                                     
  EQUITY                                                                        
  Series B                                                                      
  Convertible                                                                   
  Perpetual                                 321,213                 304,701     
  Preferred                                                                     
  Stock                                                                         
  STOCKHOLDERS'                                                                 
  EQUITY                                                                        
  Common Stock                                  201                     180     
  Additional                                                                    
  paid-in                                 1,003,680                 861,953     
  capital                                                                       
  Accumulated                                                                   
  other                                        (654  )                 (305  )  
  comprehensive                                                                 
  loss                                                                          
  Accumulated                              (984,733  )             (815,941  )  
  deficit                                                                       
  TOTAL                                                                         
  STOCKHOLDERS'                              18,494                  45,887     
  EQUITY                                                                        
  TOTAL                                                                         
  LIABILITIES,                                                                  
  MEZZANINE                      $          956,459       $         922,666     
  EQUITY, AND                                                                   
  STOCKHOLDERS’                                                                 
  EQUITY                                                                        
                                                                                
PureCycle Technologies, Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
                                                                                
  (in thousands)                                                                
  Cash flows from       Nine Months Ended                                       
  operating             September 30,                                           
  activities            2026                                 2025               
 ────────────────────────────────────────────────────────────────────────────── 
  Net loss              $                     (168,792  )    $     (163,778  )  
  Adjustments to                                                                
  reconcile net loss                                                            
  to net                                                                        
  cash used in                                                                  
  operating                                                                     
  activities                                                                    
  Equity-based                                   6,609               12,668     
  compensation                                                                  
  Change in fair                               (29,058  )             1,881     
  value of warrants                                                             
  Change in fair                                                                
  value of put                                   2,256               (3,443  )  
  option                                                                        
  Depreciation                                  22,200               21,875     
  expense                                                                       
  Loss on disposal                                 426                3,765     
  of equipment                                                                  
  Amortization of                                                               
  debt issuance                                 19,804               17,335     
  costs and                                                                     
  debt discounts                                                                
  Loss on                                                                       
  extinguishment of                             34,541                    —     
  debt                                                                          
  Operating lease                                                               
  amortization                                   3,639                3,398     
  expense                                                                       
  Other                                           (439  )               938     
  Changes in                                                                    
  operating assets                                                              
  and                                                                           
  liabilities                                                                   
  Accounts                                      (2,133  )            (1,595  )  
  receivable, net                                                               
  Inventory                                     (6,388  )            (3,539  )  
  Prepaid expenses                                                              
  and other current                                 30                 (878  )  
  assets                                                                        
  Prepaid expenses                                                              
  and other                                        350                  968     
  noncurrent                                                                    
  assets                                                                        
  Accounts payable                                 634               (2,062  )  
  Accrued expenses                                                              
  and other current                             (8,783  )              (578  )  
  liabilities                                                                   
  Accrued interest                               3,387                1,820     
  Operating lease                                                               
  right-of-use                                  (3,247  )            (2,827  )  
  liabilities                                                                   
  Net cash used in                                                              
  operating                                   (124,964  )          (114,052  )  
  activities                                                                    
  Cash flows from                                                               
  investing                                                                     
  activities                                                                    
  Purchase of                                                                   
  property, plant                              (42,039  )           (27,504  )  
  and                                                                           
  equipment                                                                     
  Purchase of debt                                                              
  securities,                                 (125,705  )                 —     
  available                                                                     
  for sale                                                                      
  Sale and maturity                                                             
  of                                            68,134                    —     
  available-for-sale                                                            
  investments                                                                   
  Net cash used in                                                              
  investing                                    (99,610  )           (27,504  )  
  activities                                                                    
  Cash flows from                                                               
  financing                                                                     
  activities                                                                    
  Proceeds from                                                                 
  issuance of Series                                                            
  B                                                  —              300,000     
  Convertible                                                                   
  Perpetual                                                                     
  Preferred Stock                                                               
  Proceeds from                                                                 
  issuance of Common                           163,006               33,462     
  Stock                                                                         
  Proceeds from                                                                 
  issuance of                                  287,500                    —     
  Convertible                                                                   
  Senior Notes                                                                  
  Repurchase of                                                                 
  Green Convertible                           (241,079  )                 —     
  Notes                                                                         
  Proceeds from                                                                 
  issuance of                                        —               16,808     
  revenue bonds                                                                 
  to third parties                                                              
  Proceeds from                                                                 
  issuance of                                        —               10,063     
  revenue bonds                                                                 
  to related parties                                                            
  Payments on                                                                   
  related party                                 (3,720  )              (535  )  
  revenue bonds                                                                 
  Proceeds from                                                                 
  revolving credit                                                              
  facility                                           —               14,900     
  and related party                                                             
  note payable                                                                  
  Payments on                                                                   
  revolving credit                                                              
  facility                                           —              (14,900  )  
  and related party                                                             
  note payable                                                                  
  Proceeds from                                                                 
  exercise and                                     243                6,616     
  issuance of                                                                   
  warrants                                                                      
  Payments on                                                                   
  equipment                                     (4,027  )            (7,663  )  
  financing                                                                     
  Stock and debt                               (19,577  )            (7,624  )  
  issuance costs                                                                
  Payments to                                   (2,797  )            (4,527  )  
  repurchase shares                                                             
  Other financing                               (1,340  )               698     
  activities                                                                    
  Net cash provided                                                             
  by financing                                 178,209              347,298     
  activities                                                                    
  Net                                                                           
  (decrease)/increa…                           (46,365  )           205,742     
  in cash and                                                                   
  restricted cash                                                               
  Cash and cash                                                                 
  equivalents and                                                               
  restricted                                   168,034               41,511     
  cash, beginning of                                                            
  period                                                                        
  Cash and cash                                                                 
  equivalents and                                                               
  restricted            $                      121,669       $      247,253     
  cash, end of                                                                  
  period                                                                        
                                                                                
                                                                                
   Information Regarding Non-GAAP Financial Measures                            
                                                                                
The Company uses certain financial measures that are not calculated in          
accordance with generally accepted accounting principles in the U.S. (“GAAP”) to
supplement its financial statements. These non-GAAP financial measures provide  
additional information to investors to facilitate comparisons of past and       
present operating results, identify trends in our underlying operating          
performance, and offer greater transparency on how the Company evaluates its    
business activities. These measures are integral to the Company’s process for   
budgeting, managing operations, making strategic decisions and evaluating its   
performance.                                                                    
                                                                                
The Company’s primary non-GAAP financial measures are EBITDA and Adjusted       
EBITDA. The Company defines EBITDA as net income before interest expense,       
interest income, taxes and depreciation and amortization. Adjusted EBITDA is    
defined as EBITDA further adjusted to exclude certain non-cash items and other  
items that are not indicative of the Company’s core operating activities. These 
may include equity-based compensation expense and changes in the fair value of  
warrants and put options, and other financial items. The Company believes       
Adjusted EBITDA is valuable for investors and analysts as it provides additional
insight into the Company’s operational performance, excluding the impacts of    
certain financing, investing, and other non-operational activities. This measure
helps in comparing the Company’s current operating results with prior periods   
and with those of other companies in the Company’s industry. It is also used    
internally for allocating resources efficiently, assessing strategic decisions, 
and evaluating the performance of the Company’s management team.                
                                                                                
There are limitations to Adjusted EBITDA, including its exclusion of cash       
expenditures, future requirements for capital expenditures and contractual      
commitments, and changes in the Company’s cash requirements for working capital 
needs. Adjusted EBITDA also omits significant interest expense and related cash 
requirements for interest and payments. While depreciation and amortization are 
non-cash charges, the associated assets will often need to be replaced in the   
future, and Adjusted EBITDA does not reflect the cash required for such         
replacements. Additionally, Adjusted EBITDA does not account for income or other
taxes or necessary cash tax payments.                                           
                                                                                
Investors should use caution when comparing the Company’s non-GAAP measure to   
similar metrics used by other companies, as definitions can vary. Neither EBITDA
nor Adjusted EBITDA should be considered in isolation or as a substitute for    
GAAP financial measures. In presenting EBITDA and Adjusted EBITDA, the Company  
aims to provide investors with an additional tool for assessing the operational 
performance of the Company’s business. It serves as a useful complement to the  
Company’s GAAP results, offering a more comprehensive understanding of the      
Company’s financial health and operational efficiencies. The table at the end of
the press release provides a reconciliation from Net Income (Loss) to Adjusted  
EBITDA for the specified periods.                                               
The following table reconciles GAAP net income (loss) to Adjusted EBITDA (in
thousands):
                                                                              
                                                 Q3 2026          Q3 2025     
 ──────────────────────────────────────────────────────────────────────────── 
  Net income/(loss)                           $    6,868       $  (28,370  )  
  Plus: Interest expense                          14,763           16,235     
  Less: Interest income                           (1,969  )        (2,850  )  
  Plus: Income taxes                                   —                —     
  Plus: Depreciation and amortization              7,454            7,262     
  EBITDA                                          27,116           (7,723  )  
  Adjustments:                                                                
  Plus: Equity-based compensation                  2,103            2,903     
  Plus/(Less): Change in fair value of           (58,553  )       (23,745  )  
  warrants                                                                    
  Plus/(Less): Change in fair value of put         1,339                —     
  option                                                                      
  Adjusted EBITDA                             $  (27,995  )    $  (28,565  )  
                                                                              
Key Performance Indicators
                                                            
                                 Q3 2026  Q2 2026  Q3 2025  
  Consolidated                                              
  Revenue ($MM)                     $2.3     $4.5     $2.4  
  Monthly Ops. Spending ($MM)*      $7.8     $8.4     $8.3  
  Ironton Purification                                      
  PureFive® Production (MM lbs)      5.2      4.5      7.3  
  Other Production (MM lbs)          0.9      0.1      0.6  
  Feedstock Processed (MM lbs)       5.8      5.0      8.1  
                                                            
Other Production includes co-products and other saleable volumes, net of
reprocessed material. *Monthly operations spending is the average monthly cash
spend on operations and corporate costs, excluding materials purchases,
turnaround costs (in project spend), and severance and other costs to implement
the savings measures. All periods are on the same basis, with Q2 2026 restated
to include equipment lease payments ($8.3 million per month as previously
reported). ###

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PCT/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.